We therefore determined SMN protein and mRNA levels in blood and skin-derived fibroblasts from a large cohort of children and adults with SMA and matched healthy controls using ELISA and qPCR methodology. The gene discussed is SMN2; the disease is proximal spinal muscular atrophy.